ATYR PHARMA INC (LIFE)
US0021202025 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.81M | 22.54M | 10.00M | 2.30M | 17.00M | |||
| Marketable Securities | 77.69M | 75.62M | 56.20M | 105.60M | 14.70M | |||
| Receivables | 2.48M | 2.44M | 11.80M | 400.00K | 2.00M | |||
| Other Current Assets | 9.94M | 2.39M | 3.00M | 5.20M | 1.80M | |||
| Total Current Assets | 96.92M | 102.99M | 80.90M | 113.60M | 35.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.99M | 14.05M | 11.60M | 1.80M | 3.00M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.34M | 3.62M | 3.40M | 200.00K | 200.00K | |||
| Total Non-Current Assets | 16.34M | 17.66M | 14.90M | 1.90M | 3.20M | |||
| TOTAL ASSETS | 113.25M | 120.65M | 95.80M | 115.50M | 38.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 507.00K | 497.00K | 300.00K | N/A | 0.00 | |||
| Accrued Expenses | 10.58M | 12.39M | 10.50M | 5.00M | 4.40M | |||
| Accounts Payable | 4.89M | 3.53M | 3.10M | 1.00M | 1.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 15.98M | 16.42M | 13.90M | 6.00M | 5.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.30M | 1.43M | 1.00M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.69M | 12.34M | 9.60M | 400.00K | 1.40M | |||
| Total Non-Current Liabilities | 12.81M | 13.58M | 10.40M | 200.00K | 1.20M | |||
| TOTAL LIABILITIES | 28.79M | 30.00M | 24.30M | 6.20M | 7.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -483.51M | -468.02M | -417.60M | -372.30M | -338.50M | |||
| Additional Paid In Capital | 568.07M | 558.69M | 489.50M | 481.80M | 370.20M | |||
| Minority Interest | -188.00K | -180.00K | -190.00K | -190.00K | -190.00K | |||
| Common Shares | 68.00K | 63.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -158.00K | -74.00K | -400.00K | -300.00K | 0.00 | |||
| Shares Outstanding | 68.35M | 63.29M | 29.50M | 27.80M | 11.00M | |||
| Tangible Book Value per Share | 1.24 | 1.43 | 2.42 | 3.93 | 2.88 | |||
| Total Shareholders' Equity | 84.47M | 90.66M | 71.50M | 109.30M | 31.70M | |||
| TOTAL LIABILITIES AND EQUITY | 113.25M | 120.65M | 95.80M | 115.50M | 38.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.01 | N/A | N/A | |||
| Current Ratio | 6.07 | 6.27 | 5.82 | 18.93 | 6.02 | |||
| Return On Assets (ROA) | -47.62% | -41.76% | -47.33% | -29.24% | -41.91% | |||
| Return On Equity (ROE) | -63.85% | -55.58% | -63.41% | -30.90% | -51.17% | |||
All data in USD